Quick Answer
IMMUCELL CORP /DE/ reported Research And Development Expense of $3.04 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed a decrease of -22.0% in Research And Development Expense from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $271.9 thousand | Q3 2013: $290.9 thousand | Q4 2013: $325.0 thousand | Q1 2014: $594.2 thousand | Q2 2014: $760.7 thousand | Q3 2014: $361.2 thousand | Q4 2014: $463.0 thousand | Q1 2015: $330.7 thousand | Q2 2015: $271.8 thousand | Q3 2015: $301.7 thousand | Q4 2015: $331.1 thousand | Q1 2016: $302.4 thousand | Q2 2016: $380.4 thousand | Q3 2016: $307.7 thousand | Q4 2016: $253.7 thousand | Q1 2017: $339.6 thousand | Q2 2017: $387.0 thousand | Q3 2017: $585.8 thousand | Q1 2018: $582.9 thousand | Q2 2018: $761.9 thousand | Q3 2018: $908.8 thousand | Q1 2019: $910.4 thousand | Q2 2019: $820.1 thousand | Q3 2019: $984.7 thousand | Q1 2020: $974.4 thousand | Q2 2020: $1.09 million | Q3 2020: $1.12 million | Q1 2021: $1.03 million | Q2 2021: $1.00 million | Q3 2021: $1.05 million | Q1 2022: $1.04 million | Q2 2022: $1.14 million | Q3 2022: $1.27 million | Q1 2023: $1.11 million | Q2 2023: $1.10 million | Q3 2023: $1.12 million | Q1 2024: $1.26 million | Q2 2024: $1.03 million | Q3 2024: $786.1 thousand | Q1 2025: $756.8 thousand | Q2 2025: $831.9 thousand | Q3 2025: $694.3 thousand.
- Over the full 17 years of available data (2009 to 2025), IMMUCELL CORP /DE/'s Research And Development Expense has grown by 84.9%.
- Historical annual values: Fiscal year 2025: $3.04 million | Fiscal year 2024: $3.90 million | Fiscal year 2023: $4.39 million | Fiscal year 2022: $4.49 million | Fiscal year 2021: $4.17 million | Fiscal year 2020: $4.35 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $3.52 million | Fiscal year 2017: $2.05 million | Fiscal year 2016: $1.24 million | Fiscal year 2015: $1.24 million | Fiscal year 2014: $2.18 million | Fiscal year 2013: $1.15 million | Fiscal year 2012: $917.6 thousand | Fiscal year 2011: $1.72 million | Fiscal year 2010: $1.49 million | Fiscal year 2009: $1.64 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: